This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2001:15 Suppl 5:S27-34.

doi: 10.1097/00002030-200100005-00005.

Mechanisms of HIV-1 drug resistance

B Larder¹

Affiliations

PMID: 11816171
DOI: 10.1097/00002030-200100005-00005

Review

Mechanisms of HIV-1 drug resistance

B Larder. AIDS. 2001.

. 2001:15 Suppl 5:S27-34.

doi: 10.1097/00002030-200100005-00005.

Author

B Larder¹

Affiliation

¹ Visible Genetics Inc., 184 Cambridge Science Park, Cambridge CB4 0GA, UK. blarder@visgen.com

PMID: 11816171
DOI: 10.1097/00002030-200100005-00005

No abstract available

PubMed Disclaimer

Similar articles

Current insights into reverse transcriptase inhibitor-associated resistance.
Wainberg MA, White AJ. Wainberg MA, et al. Antivir Ther. 2001;6 Suppl 2:11-9. Antivir Ther. 2001. PMID: 11678474 No abstract available.
Revisiting the concept of a genetic barrier to resistance.
Rusconi S. Rusconi S. J HIV Ther. 2006 Dec;11(4):81-3. J HIV Ther. 2006. PMID: 17578211 Review. No abstract available.
Antiretroviral Resistance Mutations (revised April 2001).
International AIDS Society-USA Resistance Testing Panel; HIV InSite. International AIDS Society-USA Resistance Testing Panel, et al. HIV Clin Trials. 2001 Jul-Aug;2(4):346-55. doi: 10.1310/8FXB-B0EK-D525-BVU3. HIV Clin Trials. 2001. PMID: 11590539 No abstract available.
A fossil record of zidovudine resistance in transmitted isolates of HIV-1.
Kuritzkes DR. Kuritzkes DR. Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13485-7. doi: 10.1073/pnas.251559398. Proc Natl Acad Sci U S A. 2001. PMID: 11717419 Free PMC article. Review. No abstract available.
Clinical utility of resistance testing.
Stebbing J, Gazzard BG. Stebbing J, et al. J HIV Ther. 2002 Nov;7(4):75-9. J HIV Ther. 2002. PMID: 12733604 No abstract available.

See all similar articles

Cited by

The spread, treatment, and prevention of HIV-1: evolution of a global pandemic.
Cohen MS, Hellmann N, Levy JA, DeCock K, Lange J. Cohen MS, et al. J Clin Invest. 2008 Apr;118(4):1244-54. doi: 10.1172/JCI34706. J Clin Invest. 2008. PMID: 18382737 Free PMC article. Review.
The Prevalence of Pretreatment Drug Resistance and Transmission Networks Among Newly Diagnosed HIV-1-Infected Individuals in Nanning, Guangxi, China.
Su Q, Li Y, Huang T, Wei L, He J, Huang Y, Mo G, Qin J, Tao C, Huang X, Ye L, Liang H, Liang B, Huang J. Su Q, et al. Pathogens. 2025 Mar 31;14(4):336. doi: 10.3390/pathogens14040336. Pathogens. 2025. PMID: 40333122 Free PMC article.
Molecular Epidemiology and Trends in HIV-1 Transmitted Drug Resistance in Mozambique 1999-2018.
Ismael N, Wilkinson E, Mahumane I, Gemusse H, Giandhari J, Bauhofer A, Vubil A, Mambo P, Singh L, Mabunda N, Bila D, Engelbrecht S, Gudo E, Lessells R, de Oliveira T. Ismael N, et al. Viruses. 2022 Sep 9;14(9):1992. doi: 10.3390/v14091992. Viruses. 2022. PMID: 36146798 Free PMC article.
Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule CCR5 inhibitor.
Kuhmann SE, Pugach P, Kunstman KJ, Taylor J, Stanfield RL, Snyder A, Strizki JM, Riley J, Baroudy BM, Wilson IA, Korber BT, Wolinsky SM, Moore JP. Kuhmann SE, et al. J Virol. 2004 Mar;78(6):2790-807. doi: 10.1128/jvi.78.6.2790-2807.2004. J Virol. 2004. PMID: 14990699 Free PMC article.
New reporter cell line to evaluate the sequential emergence of multiple human cytomegalovirus mutations during in vitro drug exposure.
Gilbert C, Boivin G. Gilbert C, et al. Antimicrob Agents Chemother. 2005 Dec;49(12):4860-6. doi: 10.1128/AAC.49.12.4860-4866.2005. Antimicrob Agents Chemother. 2005. PMID: 16304146 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Medical
- MedlinePlus Health Information